PREXTON THERAPEUTICS

Prexton Therapeutics is a Swiss-based biopharmaceutical company, founded in 2012 by Francois Conquet and MS Ventures as part of the Merck Serono Entrepreneur Partnership Program, a facility to support the creation of spin-offs from Merck Serono. Prexton Therapeutics applies a new scientific approach that fully integrates molecular, behavioural and chemistry technologies to address Parkinson’s disease and other brain disorders. Prexton Therapeutics uses its powerful discovery platform to target specific novel compounds focused on the treatment of Parkinson’s disease.

#People #Financial #Website #More

PREXTON THERAPEUTICS

Social Links:

Industry:

Health Care Medical Pharmaceutical

Founded:

2012-01-01

Address:

Plan-les-ouates, Geneve, Switzerland

Country:

Switzerland

Website Url:

http://www.prextontherapeutics.com

Total Employee:

Status:

Closed

Contact:

+41227069010

Email Addresses:

[email protected]

Total Funding:

41.07 M USD

Technology used in webpage:

Domain Not Resolving Euro Infomaniak Network

Current Advisors List

alan-oconnell_image

Alan O'Connell Board of Director @ Prexton Therapeutics
Board_member

marco-boorsma_image

Marco Boorsma Board of Director @ Prexton Therapeutics
Board_member

jasper-bos_image

Jasper Bos Boards of Directors @ Prexton Therapeutics
Board_member

Founder

françois-conquet_image

François Conquet

Investors List

ysios-capital_image

Official Site Inspections

http://www.prextontherapeutics.com

Host Informations
Whois Informations

Loading ...